TrialStem cells translational medicine2012

Functional impairment of human resident cardiac stem cells by the cardiotoxic antineoplastic agent trastuzumab.

Andreas S Barth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.